Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
How I remember being singled out by name by Neil Woodford at the Woodford Patient Capital Trust (WPCT) AGM as a purveyor of fake news on May 16 this year. Neil was adamant: he was doing brilliantly I was making thisngs up. Today he was fired by his flagship fund and his City career is in its final weeks and will end in disgrace. Investors who ignored four years of warnings on this site will have lost billions. I reflect on all of this, where it leaves various parties including Neil's other vehicles, disgraced Hargreaves Landsdowne (HL.) and other disgraced promoters. I also comment on another vindication, the mercy takeover of Brady (BRY) at just 10p after I forced it to fess up to its finacial woes, with the shares at 26p just three weeks ago.
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.